However, classic biomarkers of PAH, such as endothelial dysfunction, pulmonary artery hyperresponsiveness to 5-HT, and downregulation of BMPR2 and Kv1.5, were unaffected by quercetin [106]. Here, KCNA5 is linked to pulmonary arterial hypertension.